ORX:STO
Orexo AB
SEKÂ 0.98
arrow_downward
-1.70%(-0.017) 1D
Nov 20, 5:29:34 PM GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
SEKÂ 1.05
High
SEKÂ 1.05
Low
SEKÂ 0.93
Mkt. cap
345.30M
Avg. vol.
785.30K
Volume
286.21K
P/E ratio
0.07
52-wk high
SEKÂ 22.55
52-wk low
SEKÂ 0.80
EPS
SEKÂ 13.61
Shares outstanding
35.13M
No. of employees
55
Open
SEKÂ 1.05
High
SEKÂ 1.05
Low
SEKÂ 0.93
Mkt. cap
345.30M
Avg. vol.
785.30K
Volume
286.21K
P/E ratio
0.07
52-wk high
SEKÂ 22.55
52-wk low
SEKÂ 0.80
EPS
SEKÂ 13.61
Shares outstanding
35.13M
No. of employees
55
News stories
From web sources and news partners
FOREX.com
·
2 hours ago
S&P 500, Nasdaq 100 Drive into Correction Territory
TradingKey
·
9 hours ago
S&P 500 Falls Below 200-Day Moving Average: Buy-the-Dip Opportunity or Bear Market Warning?
Beinsure
·
14 hours ago
Vanguard S&P 500 ETF: How investing in VOO could build a $1 mn portfolio
cwibc.co.id
·
3 hours ago
Wall Street Sell-Off Pushes S&P 500 and Dow Into Correction
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com